Atlas Trials

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Clinical trial NCT04358068 · TERMINATED

Trial details

NCT number
NCT04358068
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19SARS-CoV 2
Start date
2020-05-13
Primary completion
2020-07-08
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.